Skip to McMaster NavigationSkip to Site NavigationSkip to main content
The Forge Logo

Built by McMaster University

The Forge


VoxNeuro Announces Significant Milestones on its Mission to Become “The Brain Company”

March 30, 2022

The Forge client VoxNeuro Inc. has met three significant developments recently. The Software as a Medical Device (SaMD) brain health company that analyzes brain-based biomarkers to assess cognitive function has announced a number of significant developments including: (i) receipt of US patent 11278230 entitled “Systems and methods for cognitive health assessment” which provides protection for VoxNeuro’s competitive advantage (specific EEG-based neuropsychological assessments that generate event-related potentials associated with key cognitive functions, and the output of a cognitive health report), (ii) the establishment of a US-based expert clinical study program to assist in expanding VoxNeuro’s product offerings across a range of neurological pathologies, and (iii) the retainer of a seasoned executive, Jason Flowerday, as Chief Executive Officer.

Read more about these achievements in the Financial Post article published on March 30, 2022.